Pharmacogenomics In Treatment Research Articles

S2-3 Pharmacogenomics of ASA/NSAID intolerant asthma(AIA) in Korea(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-3 Pharmacogenomics of ASA/NSAID intolerant asthma(AIA) in Korea(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-6 Genetic predisposition to severe cutaneous adverse drug response in Japan(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-6 Genetic predisposition to severe cutaneous adverse drug response in Japan(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-4 Genetic Susceptibility and Pharmacogenomics of Cutaneous Adverse Drug Reactions(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-4 Genetic Susceptibility and Pharmacogenomics of Cutaneous Adverse Drug Reactions(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-5 Predisposition to severe cutaneous ADRS in Europe(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-5 Predisposition to severe cutaneous ADRS in Europe(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-2 PHARMACOGENOMICS OF ANTI-LEUKOTRIENE DRUGS IN ASTHMA(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-2 PHARMACOGENOMICS OF ANTI-LEUKOTRIENE DRUGS IN ASTHMA(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-1 Pharmacogenetics of anti-leukotriene drugs(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)

S2-1 Pharmacogenetics of anti-leukotriene drugs(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)